# Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

> **NCT00239902** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 396 (—)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** FTY720

## Key facts

- **NCT ID:** NCT00239902
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2004-11
- **Final completion:** —
- **Target enrollment:** 396 (—)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239902, "Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00239902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*